Fredag 27 December | 02:32:29 Europe / Stockholm

Bifogade filer

Kalender

Tid*
2025-08-28 08:00 Kvartalsrapport 2025-Q2
2025-05-26 N/A Årsstämma
2025-05-07 08:00 Bokslutskommuniké 2024
2024-11-19 - Extra Bolagsstämma 2024
2024-08-29 - Kvartalsrapport 2024-Q2
2024-04-29 - X-dag ordinarie utdelning ABS 0.00 NOK
2024-04-26 - Årsstämma
2024-04-09 - Bokslutskommuniké 2023
2023-09-29 - Kvartalsrapport 2023-Q2
2023-04-24 - X-dag ordinarie utdelning ABS 0.00 NOK
2023-04-21 - Årsstämma
2023-03-29 - Bokslutskommuniké 2022
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-06 - X-dag ordinarie utdelning ABS 0.00 NOK
2022-05-05 - Årsstämma
2022-04-07 - Bokslutskommuniké 2021
2021-11-10 - Extra Bolagsstämma 2021
2021-08-26 - Kvartalsrapport 2021-Q2

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriBioteknik
Arctic Bioscience är ett bioteknikföretag som utvecklar och kommersialiserar läkemedelsprodukter och kosttillskott baserade på bioaktiva marina råvaror. Företaget utvecklar HRO350, en ny läkemedelskandidat för behandling av patienter med mild till måttlig psoriasis. Kosttillskott säljs globalt både som bulkingredienser och som färdiga produkter under varumärket ROMEGA, till både företag och privatkunder.
2021-10-25 12:20:31

Notice of extraordinary general meeting (EGM) - new date reference is made to the stock exchange announcement from Arctic Bioscience AS (the Company), published 19 October at 14:18 CET "Notice of extraordinary general meeting: Marita Holstad proposed as new board member ".

Due to complications in distribution, the notice and regulatory documentation did not reach all shareholders of Arctic Bioscience AS.

Thus, in order to ensure that the EGM is convened in accordance with prevailing regulations, the Board of Directors have decided that the EGM is moved to 10 November 2021 and a new Notice is attached to this release.

Due to the corona pandemic, the Board of Directors has resolved that the Extraordinary General Meeting will be held as a digital meeting in accordance with section 5-8 of the Norwegian Private Limited Liability Company's Act (as amended as from 1 June 2021).

Shareholders are encouraged to cast their votes in advance of the General Meeting or grant the Chair of the Board a proxy, with or without voting instructions.

Deadline for registration of attendance, advance votes, proxy or instructions is 9 November 2021 at 3pm (CET). For attendance to the live event, please follow the instruction in the notice.

The EGM will be on 10 November at 1pm CET on Microsoft Teams. Please follow the instructions in the Notice for attendance.